Л. Д. Латынцева

ORCID: 0000-0003-1913-5231
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Disease and Adiposity
  • Diet and metabolism studies
  • Hormonal Regulation and Hypertension
  • Diabetes Treatment and Management
  • Adipose Tissue and Metabolism
  • Gastroesophageal reflux and treatments
  • Eosinophilic Esophagitis
  • Sleep and related disorders
  • Long-Term Effects of COVID-19
  • Blood Pressure and Hypertension Studies
  • Restless Legs Syndrome Research
  • Esophageal Cancer Research and Treatment
  • Sodium Intake and Health
  • Cardiac Imaging and Diagnostics
  • Liver Disease Diagnosis and Treatment
  • Nutritional Studies and Diet
  • Retinoids in leukemia and cellular processes
  • Acute Myocardial Infarction Research
  • Blood properties and coagulation
  • Hematological disorders and diagnostics
  • Pain Management and Treatment
  • Cancer, Lipids, and Metabolism
  • Inflammasome and immune disorders
  • Bee Products Chemical Analysis

Institute of Cytology and Genetics
2018-2025

Research Institute of Therapy and Preventive Medicine
2019-2024

Novosibirsk State Medical University
2018

Tver State Medical University
2018

Ministry of Health of the Russian Federation
2018

Aim: to assess the fat depot compartments and some cardiometabolic risk markers in patients with chronic heart failure preserved ejection fraction (CHFpEF), prediabetes abdominal obesity. Patients Methods: this randomized open single-center study was carried out Research Institute for Therapy Preventive Medicine — Branch of Federal Center Cytology Genetics Siberian RAS included 64 subjects (32 them were males) CHFpEF, The standard general clinical examination laboratory tests, measurements...

10.32364/2587-6821-2023-7-1-22-29 article EN cc-by Russian Medical Inquiry 2023-01-01

The current state of the Russian and foreign regulatory framework for off-label prescription medicines is presented in article. existing problems this specific drug therapy possible solutions are described. Unfortunately, there some gaps legislation regarding medication use. Based on clinical reality, cases, “off-label” drugs can be justified by condition patient, lack alternative approved drugs, availability published scientific data that create prerequisites effectiveness approach. When...

10.20996/1819-6446-2019-15-1-130-134 article EN cc-by Rational Pharmacotherapy in Cardiology 2019-03-03

Научно-исследовательский институт терапии и профилактической медицины

10.15829/1560-4071-2018-5-74-80 article RU cc-by Russian Journal of Cardiology 2018-06-02

Considering the increasing amount of elderly people in Russia and world, an active study arterial hypertension this group is actual clinically demanded task. The strategic direction defining treatment tactic such patients, especially over 80 years old, determination their functional status presence frailty syndrome, which not synonymous with comorbidity obligatory early aging companion, but specifies need for a personalized approach hypertension, even complete abolition antihypertensive...

10.37586/2686-8636-1-2020-64-73 article EN cc-by Russian Journal of Geriatric Medicine 2020-02-14

Insulin resistance, which is a fundamental pathogenetic factor of prediabetes, closely associated with abdominal obesity on the one hand and development cardiovascular diseases, heart failure (HF), other. The role insulin resistance multifaceted consists in acceleration atherosclerosis, formation left ventricular myocardial hypertrophy, including through mechanisms that do not depend blood pressure, as well its diastolic dysfunction. latter starting point for HF preserved ejection fraction...

10.14341/dm12916 article EN cc-by-nc-nd Diabetes Mellitus 2022-12-28

Acute pancreatitis is one of the most common gastrointestinal causes for hospitalization after acute appendicitis. Despite recent advances in treatment methods, mortality from and its complications remains high. Hypertriglyceridemia an underestimated cause pancreatitis, accounting 10% among other etiological factors. Timely diagnosis hypertriglyceridemia, a personalized approach, selection adequate lipid-lowering therapy allow reducing risk developing and/or preventing recurrent...

10.17802/2306-1278-2020-9-4-114-123 article EN cc-by Complex Issues of Cardiovascular Diseases 2020-12-18

Chronic heart failure is a global cardiac problem. The last decade can rightly be called breakthrough in the treatment of this nosology, due to emergence new group drugs – SGLT2 inhibitors (gliflozins), which, both patients with initial different ejection fraction, and presence risk factors for its development, have persistent positive impact on number hospitalizations failure. A pleiotropic effects are also attractive clinician, which include moderate weight loss, decrease body fat visceral...

10.18699/ssmj20220601 article EN cc-by Сибирский научный медицинский журнал 2022-12-25

The article presents step by international CARE guidelines (CAse REport), which regulate the structure of description a clinical case and include checklist 13 points. This form presentation material does not create any difficulties in understanding, require long period time to prepare publication for author, demonstrating unique personalized experience informing medical community about interesting manifestations, diagnostic or therapeutic approaches within particular nosology, as well...

10.21518/ms2023-440 article EN cc-by-nc-nd Meditsinskiy sovet = Medical Council 2024-01-20

Background. The problem of urinary tract infections, including recurrent cystitis, and the choice effective safe means treatment prevention, taking into account increasing burden antibiotic resistance, are extremely relevant. Aim. To evaluate effectiveness safety herbal medicine Canephron® N for prevention exacerbations cystitis its effect on metabolic parameters in patients with type 2 diabetes mellitus sodium glucose cotransporter inhibitors. Material methods. A prospective, randomized,...

10.26442/00403660.2024.04.202691 article EN cc-by-nc Terapevticheskii arkhiv 2024-05-02

Aim. To study the effect of extended-release (XR) metformin on humoral cardiometabolic markers and lipid peroxidation parameters in patients with heart failure preserved ejection fraction (HFpEF), prediabetes abdominal obesity (AO). Material methods. The included 64 people (men – 50%, median age 58 [55,25; 59,75] years) HFpEF, AO. All (groups A B) received optimal therapy for HFpEF. In group (n=32), XR 1000-1500 mg/day was additionally prescribed. general clinical examination carried out,...

10.15829/1728-8800-2024-4100 article EN cc-by CARDIOVASCULAR THERAPY AND PREVENTION 2024-07-24

BACKGROUND : Considering the role of visceral adipose tissue deposition in pathogenesis heart failure with preserved ejection fraction (HFpEF) and positive effect metformin on weight loss, this drug compartments patients HFpEF is interest. AIM: To study extended-release (XR) various fat depots parameters insulin-glucose homeostasis HFpEF, prediabetes abdominal obesity (AO). MATERIALS AND METHODS Study design: single-center, open-ended, randomized, prospective, controlled. The registration...

10.14341/dm13189 article EN cc-by-nc-nd Diabetes Mellitus 2024-09-04

Introduction . Chronic heart failure with preserved ejection fraction (CHpEF) is a heterogeneous syndrome variety of pathophysiological factors, including obesity and impaired carbohydrate metabolism associated an increase in visceral adipose tissue. Due to the positive effect metformin on weight loss, recent years special attention has been paid its fat depots. Aim To study effects XR after 12 months administration various depots glucose parameters patients CHpEF, prediabetes abdominal...

10.21518/ms2024-347 article EN cc-by-nc-nd Meditsinskiy sovet = Medical Council 2024-11-01

Клинический случай в практике врачаинтерниста: пациентка с высокой скоростью оседания эритроцитов Батлук Т. И. 1 м.н.с.лаборатория профилактической медицины Цыганкова О.В.1,2 д.м.н., научный сотрудник, лаборатория клинических, биохимических и гормональных исследований терапевтических заболеваний : доцент, кафедра неотложной терапии эндокринологией профпатологией ФПК ППВ 2 Латынцева Л. Д. к.м.н., заслуженный врач РФ, заведующая, терапевтическое отделение клиники НИИТПМ, старший сотрудник лаборатории

10.29234/2308-9113-2018-6-1-110-118 article RU Medicina 2018-01-01

Understanding the molecular mechanisms of atherosclerotic vascular lesions formation is necessary both for assessing risks cardiovascular diseases and finding approaches to their therapy. The task remains relevant, despite large number studies carried out, because there are differences in factors genetic predisposition atherosclerosis its complications between different ethno-territorial groups. aim this study was search variants pattern recognition receptors associated with lipid metabolism...

10.18699/ssmj20230410 article EN cc-by Сибирский научный медицинский журнал 2023-08-30

Aim of the study was to investigate main components lipid spectrum blood serum in patients with coronary artery disease, depending on level estradiol (E2), testosterone (T) and age. Material methods . We examined 161 men aged 35–65 years (median [lower quartile; upper quartile] 53.1 [40.1; 59.4] years) a history myocardial infarction more than 30 days before inclusion study. Patients were divided into groups by age (35–55 56–65 years), as well according content sex hormones: T ≥ 12 nmol/l...

10.52727/2078-256x-2023-19-4-404-414 article EN cc-by Ateroscleroz 2023-12-15

ЦЕЛЬ: изучение компартментов жировых депо и некоторых кардиометаболических гуморальных марке-
 ров у пациентов с хронической сердечной недостаточностью сохраненной фракцией выброса (ХСНсФВ),
 предиабетом абдоминальным ожирением.
 МАТЕРИАЛЫ И МЕТОДЫ: в интервенционное одноцентровое открытое рандомизированное про-
 спективное контролируемое исследование на базе НИИ терапии профилактической медицины филиала
 ИЦиГ СО РАН (г. Новосибирск) включено 64 человека (из них 32 –...

10.14341/diaconfiii25-26.05.23-98 article RU Конференция по лечению и диагностике сахарного диабета «Фундаментальная и клиническая диабетология в 21 веке: от теории к практике» 2023-06-28

The clinical case of the successful use myocardial cytoprotector trimetazidine as a universal anti-ischemic agent in patient with hemodynamic angina due to bridging is described. pathogenetic rationale for this prescription presented.

10.15829/1728-8800-2019-6-116-120 article EN cc-by CARDIOVASCULAR THERAPY AND PREVENTION 2019-12-22
Coming Soon ...